Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 100
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Inquiry ; 60: 469580231214751, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38037829

RESUMO

Chlorhexidine gluconate (CHG)-containing dressings are recommended to prevent central line associated bloodstream infections (CLABSIs) and other catheter-related infections. This study compared the effect of 2 CHG dressings on CLABSI, cost of care, and contact dermatitis. A retrospective analysis was conducted using the Premier Healthcare Database of hospitalized patients (n = 53 149) with central venous catheters (CVCs) and receiving either a transparent CHG gel dressing (n = 14 488) or an opaque CHG sponge dressing (n = 38 661) between January 2019 and September 2020. Two cohorts (n = 14 488 each), CHG-Gel and CHG-Sponge, were matched 1:1 using a propensity score method on 33 patient and facility characteristics. CLABSI and contact dermatitis rates, hospital length of stay (LOS), and hospitalization costs were compared using mixed-effect multiple regression. This approach effectively controlled for random clustering effects across hospitals and patients' Diagnosis-Related Group (DRG) classifications. CHG gel dressings were associated with a 41% decrease in CLABSI rates (P = .0008) compared to CHG sponge dressings (0.35%vs 0.60%). A 0.4-day shorter LOS (9.53vs 9.90 days, P = .0001) and a cost saving of $3576 per hospital stay ($40 197 vs $43 774, P = .0179) was observed with CHG gel dressing use. There was no statistically significant difference in contact dermatitis rates (P = .7854) between the CHG-Gel and CHG-Sponge cohorts. The findings of this study suggest that the use of CHG gel dressings may be more effective in reducing the risk of CLABSIs and associated clinical costs compared to CHG sponge dressings in hospitalized patients. Moreover, there appears to be no significant discrepancy in contact dermatitis rates between CHG gel and CHG sponge dressings. Healthcare providers may consider using CHG gel dressings as a standard practice for patients with CVCs to reduce the risk of infections and improve patient outcomes.


Assuntos
Anti-Infecciosos Locais , Cateterismo Venoso Central , Dermatite de Contato , Sepse , Humanos , Anti-Infecciosos Locais/uso terapêutico , Bandagens , Cateterismo Venoso Central/efeitos adversos , Cateterismo Venoso Central/métodos , Dermatite de Contato/etiologia , Tempo de Internação , Estudos Retrospectivos , Sepse/etiologia , Sepse/prevenção & controle , Pesquisa Comparativa da Efetividade
2.
Regul Toxicol Pharmacol ; 128: 105088, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34838871

RESUMO

The whole or ground seeds of the food ingredient Nigella sativa L., known in Western culture as "black cumin" or "black caraway", has a three-millennial history of use in Middle- and Far-Eastern cultures as a food ingredient. The seed and its extracts have also been increasingly reported as a successful therapeutic agent with efficacy often attributed to the presence of the powerful antioxidant, thymoquinone. However, quantitative analysis of the seed (especially the volatile fraction) yields widely variable results, which may be due to one or a combination of different crop origins or possible varietal differences, contamination/adulteration, method of extraction, stage of maturation of the extracted seed and other factors. Nonetheless, despite the reported wide variability in bioactive constituents, many publications cite quantifiable outcomes in in vitro and in vivo toxicity testing and in clinical trials. There are a few reports describing allergic reactions in humans when N. sativa extracts are applied to the skin. Notwithstanding the foregoing, N. sativa seeds, used as a food ingredient at historical levels of consumption and as traditionally practiced are safe and Generally Recognized As Safe.


Assuntos
Ingredientes de Alimentos/toxicidade , Nigella sativa/toxicidade , Animais , Dermatite de Contato/etiologia , Relação Dose-Resposta a Droga , Humanos , Camundongos , Nigella sativa/química , Nigella sativa/classificação , Nigella sativa/crescimento & desenvolvimento , Óleos Voláteis/administração & dosagem , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Plantas Medicinais/classificação , Plantas Medicinais/toxicidade , Ratos , Sementes , Especiarias , Estados Unidos , United States Food and Drug Administration/normas
3.
Wound Manag Prev ; 65(1): 14-19, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30724745

RESUMO

Peristomal skin complications are a common problem for persons with an ileostomy. PURPOSE: The purpose of this pilot study was to solicit user feedback and perform an initial assessment of the performance of a new barrier seal designed to decrease the risk of chemical-induced dermatitis. METHODS: Seven (7) potential participants who were at least 18 years of age, >6 months post surgery, with an end or loop ileostomy and unbroken peristomal skin, and who were capable of changing their appliance themselves or had the availability of care assistance were identified and recruited by the stoma care nurse at the University Hospital, Limerick, Ireland. At the initial visit and after 1 and 2 weeks, participants were asked to rate device comfort, security, and handling; skin condition was assessed by the research nurse using the Ostomy Skin Tool. Descriptive statistics were used to tabulate the results. RESULTS: Five (5) participants completed the study. Discoloration, erosion, and tissue overgrowth scores improved in 3 of 5 patients, and the mean Ostomy Skin Tool score decreased from 5.4 ± 2.19 at the initial assessment to 4 ± 1.87 at the week 2 visit. Comfort, handling, and security ratings increased from a median of 8 at the beginning of the study to 10 at week 2. CONCLUSION: Initial patient feedback regarding the new product was positive, and skin assessment results suggest the new seal may help improve peristomal skin condition. Larger studies with longer patient follow-up are needed to confirm the results of this pilot evaluation.


Assuntos
Ileostomia/psicologia , Satisfação do Paciente , Higiene da Pele/psicologia , Higiene da Pele/normas , Adulto , Idoso , Dermatite de Contato/etiologia , Dermatite de Contato/psicologia , Feminino , Humanos , Ileostomia/efeitos adversos , Ileostomia/métodos , Irlanda , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Higiene da Pele/métodos
5.
J Ethnopharmacol ; 192: 302-308, 2016 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-27394387

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Boldoa purpurascens Cav. (Nyctaginaceae) is a plant species used in traditional medicine in Cuba as a diuretic. AIM OF THE STUDY: The aim of the present investigation was to evaluate the safety profile of a hydroalcoholic extract from leaves of Boldoa purpurascens. MATERIALS AND METHODS: First, an experimental study to assess the oral acute toxicity at a dose of 2000mg/kg body weight of the extract was carried out. Potential genotoxicity of the extract was evaluated using the Ames test and the micronucleus induction assay in mouse bone marrow. In the Ames test a concentration range of 50, 100, 150, 300 and 500µg/plate was tested. In the micronucleus induction assay, doses of 500, 1000 and 2000mg/kg of body weight were tested. For completeness, since the extract contains saponins, the evaluation of the hemolytic activity, ocular and skin irritation were included. RESULTS: No signs or symptoms of toxicity were observed in the oral acute toxicity test (body weight at baseline, seven days and end of the experiment of 236.41±20.07, 256.81±30.44 and 240.02±26.16 respectively for the treated group). The hydroalcoholic extract from the leaves was not mutagenic in the Ames test, and no genotoxicity was observed in the micronucleus assay. A hemolysis test at concentration of 1mg/mL confirmed hemolytic activity, which is not a safety concern since saponins are not absorbed after oral administration. In order to evaluate the percentage of protein denaturation, the ocular irritability index was calculated. The extract was found to be irritating. Finally, skin irritability was evaluated and the irritation index was equal to zero. CONCLUSIONS: Based on the toxicological evaluation of a traditionally used hydroalcoholic extract from the leaves of Boldoa purpurascens we can confirm the safety of its oral use.


Assuntos
Nyctaginaceae/toxicidade , Extratos Vegetais/toxicidade , Folhas de Planta/toxicidade , Administração Oral , Animais , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/patologia , DNA Bacteriano/efeitos dos fármacos , DNA Bacteriano/genética , Dermatite de Contato/etiologia , Dermatite de Contato/patologia , Olho/efeitos dos fármacos , Olho/metabolismo , Proteínas do Olho/metabolismo , Feminino , Hemólise/efeitos dos fármacos , Masculino , Camundongos Endogâmicos BALB C , Micronúcleos com Defeito Cromossômico/induzido quimicamente , Testes para Micronúcleos , Mutação , Nyctaginaceae/química , Fitoterapia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/isolamento & purificação , Folhas de Planta/química , Plantas Medicinais , Desnaturação Proteica , Coelhos , Ratos Sprague-Dawley , Ratos Wistar , Medição de Risco , Testes de Irritação da Pele , Solventes/química , Fatores de Tempo , Testes de Toxicidade Aguda
7.
Regul Toxicol Pharmacol ; 71(3): 515-28, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25659490

RESUMO

In the European Union animal testing has been eliminated for cosmetic ingredients while the US Cosmetic Ingredient Review Expert Panel may request data from animal studies. The use of read-across and predictive toxicology provides a path for filling data gaps without additional animal testing. The PEG cocamines are tertiary amines with an alkyl group derived from coconut fatty acids and two PEG chains of varying length. Toxicology data gaps for the PEG cocamines can be addressed by read-across based on structure-activity relationship using the framework described by Wu et al. (2010) for identifying suitable structural analogs. Data for structural analogs supports the conclusion that the PEG cocamines are non-genotoxic and not expected to exhibit systemic or developmental/reproductive toxicity with use in cosmetics. Due to lack of reliable dermal sensitization data for suitable analogs, this endpoint was addressed using predictive software (TIMES SS) as a first step (Laboratory of Mathematical Chemistry). The prediction for PEG cocamines was the same as that for PEGs, which have been concluded to not present a significant concern for dermal sensitization. This evaluation for PEG cocamines demonstrates the utility of read-across and predictive toxicology tools to assess the safety of cosmetic ingredients.


Assuntos
Aminas/toxicidade , Simulação por Computador , Cosméticos/toxicidade , Irritantes/toxicidade , Modelos Teóricos , Polietilenoglicóis/toxicidade , Testes de Toxicidade/métodos , Aminas/química , Animais , Cosméticos/química , Dermatite de Contato/etiologia , Olho/efeitos dos fármacos , Humanos , Irritantes/química , Camundongos , Estrutura Molecular , Testes de Mutagenicidade , Polietilenoglicóis/química , Medição de Risco , Pele/efeitos dos fármacos , Testes de Irritação da Pele , Software , Relação Estrutura-Atividade
9.
J Occup Environ Med ; 52(11): 1045-54, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21063182

RESUMO

OBJECTIVE: To estimate the economic burden associated with dermatitis in those aged 16 to 65 years and working in seven industry sectors (DW). METHODS: The 2004 Medical Expenditure Panel Survey and the cost-of-illness method, which aggregates health care costs and productivity losses, were used. RESULTS: The economic burden of DW was ~$1.2 billion, representing 10.5% of the cost of all skin diseases and disorders (SDD). In all private industry (ie, the sum of the seven sectors examined), cost per employed person was ~$11 for DW and $109 for SDD. In the all-services sector, one of the seven examined, cost per employed person was ~$15 for DW and $113 for SDD. CONCLUSIONS: This study provides the first published estimate of the economic burden of DW, based on a representative sample of the US population.


Assuntos
Efeitos Psicossociais da Doença , Dermatite de Contato/economia , Gastos em Saúde , Doenças Profissionais/economia , Adolescente , Adulto , Idoso , Assistência Ambulatorial/economia , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Gastos em Saúde/estatística & dados numéricos , Inquéritos Epidemiológicos , Humanos , Indústrias/classificação , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/epidemiologia , Exposição Ocupacional/efeitos adversos , Estados Unidos/epidemiologia , Adulto Jovem
10.
Biomed Mater Eng ; 19(1): 53-61, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19458446

RESUMO

Some metallic materials in dental prostheses may cause allergic hypersensitivity. Symptoms appear not only in the oral cavity, but also on hands, feet or the entire body. Release of metal ions is thought to cause the allergic reactions; micro-particles of the corrosion products of the metal and/or ionic metal hydroxides/oxides may be the allergens. The study purpose was to review clinical surveillance of dental allergic hypersensitivity in our dental hospital. From July 2000 to June 2005, 212 patients with suspected dental metal allergy were patch tested with 26 reagents, including 19 ready-made patch test reagents (Patch test reagents, Torii Pharmaceutical Corporation, Tokyo, Japan) and 9 custom-made reagents. One-hundred-and-sixty-seven patients were females (78.8%) and 45 patients were males (21.2%). A total of 148 patients (69.8%) had one or more positive patch test reactions. The most common allergens were nickel (25.0%), palladium (24.4%), chromium (16.7%), cobalt (15.9%) and stannum (12.5%). Typical allergic symptoms and diagnoses were Pustulosis palmaris et plantaris, lichen planus, stomatitis and contact dermatitis. This study indicates that dentists and dental researchers should be concerned about the allergenic potential of dental metal materials.


Assuntos
Materiais Dentários/efeitos adversos , Dermatite de Contato/diagnóstico , Dermatite de Contato/etiologia , Testes do Emplastro , Feminino , Humanos , Masculino , Teste de Materiais
11.
Klin Monbl Augenheilkd ; 226(1): 48-53, 2009 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-19173163

RESUMO

BACKGROUND: Contact allergies (CA) against active agents of topical ophthalmological therapeutics, causing inflammation of the conjunctiva and/or the lid, are usually not life-threatening, but occur not infrequently. As yet, the assessment of the CA-eliciting risk has been based on clinical data alone, while a valid epidemiological risk assessment is lacking. MATERIALS AND METHODS: The Information Network of Departments of Dermatology supplied information on diagnostic results obtained in 4,102 patients patch-tested for suspected CA to ophthalmic drugs between 1995 and 2004. Clinical prevalences were extrapolated to incidences at the German population level. These estimates served as numerator for a relative incidence (RI), which included the nationwide frequency of prescriptions collected by the WIdO, Bonn, in terms of a standardised defined daily dose (DDD) as denominator. RESULTS: The estimated annual incidence of CA ranges from 155 (atropine sulphate) to 2077 (gentamicin sulphate) and can thus be regarded as moderate. If incidence estimates are related to prescription frequencies, the highest risk was found for kanamycin and neomycin sulphate (RI > 8 / 100,000 DDD). In contrast, the RI of pilocarpine-HCl (0.3) was virtually negligible. CONCLUSIONS: The substance-specific risk of CA has been evaluated for the first time and found to differ between therapeutics (with a similar spectrum of application). CA risk should be considered in differential therapeutic decision-making.


Assuntos
Blefarite/induzido quimicamente , Blefarite/epidemiologia , Conjuntivite/induzido quimicamente , Conjuntivite/epidemiologia , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Soluções Oftálmicas/efeitos adversos , Administração Tópica , Adulto , Comorbidade , Feminino , Alemanha/epidemiologia , Humanos , Incidência , Masculino , Soluções Oftálmicas/administração & dosagem , Sistema de Registros , Medição de Risco/métodos , Fatores de Risco
12.
J Burn Care Res ; 28(6): 827-34, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17925652

RESUMO

The spectrum of cement-related injuries encompasses contact dermatitis, abrasions, ulcerations, chemical burns, and burns from explosions during the manufacturing process. The purpose of this study was to compile cement-related conditions seen in two burn units (1999-2005), literature case reports and series (1950-2006) and the (1989-2001) National Burn Repository (NBR). There were 3597 admissions in two Midwestern burn units, of which 12 cases (0.8%) were cement burns. They occurred in men, aged 15 to 64 years with a burn range of 0.25 to 10% TBSA, exposure time of 1 to 6 hours, treatment delay of 1 day to 2 weeks, hospitalization (2-14 days). Literature review of 109 cases indicated that cement-related injuries were predominantly seen in men, aged 26 to 45 years; with a cement-exposure time of 1.5 to 4 hours, treatment delay (1 day to 5 weeks), hospitalization (10-33 days), and healing time (2-7 weeks). There were 52,219 burn admissions in the NBR, of which 44 (0.08%) were cement-related burns; 95% were men with a mean age of 41 years, 6% TBSA cement burn and an 8-day hospital stay. The demographic characteristics of the burn units and NBR cases were similar to those in the literature. This preventable injury occurred primarily in the working age male patient and was associated with long healing times. Public awareness and enhanced manufacturer package warnings and education may decrease future cement-related injuries.


Assuntos
Queimaduras Químicas/epidemiologia , Materiais de Construção/efeitos adversos , Acidentes Domésticos/economia , Acidentes Domésticos/estatística & dados numéricos , Acidentes de Trabalho/economia , Acidentes de Trabalho/estatística & dados numéricos , Adolescente , Adulto , Unidades de Queimados , Queimaduras Químicas/economia , Queimaduras Químicas/etiologia , Queimaduras Químicas/terapia , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Feminino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Admissão do Paciente/estatística & dados numéricos , Sistema de Registros , Estados Unidos/epidemiologia
13.
Br J Dermatol ; 157(4): 713-22, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17596159

RESUMO

BACKGROUND: Estimated incidence rates for occupational skin disease in the U.K. are provided by voluntary surveillance schemes involving dermatologists and occupational physicians. These rates allow monitoring of occupational dermatoses, and intervention planning aimed at reducing workplace risks. OBJECTIVES: To summarize occupational skin disease reported to The Health and Occupation Reporting (THOR) network (2002-2005), and to provide baseline information for comparison with future studies of occupational skin disease in the U.K. and beyond. METHODS: Incidence rates for occupational dermatoses were calculated using THOR data as numerators, and Labour Force Survey data or information from the most recent U.K. survey on provision of occupational physician services as denominators. RESULTS: In the U.K. (2002-2005) the average annual incidence rate of work-related skin disease reported to THOR by dermatologists was 91.3 [95% confidence interval (CI) 81.8-101.1] per million, and by occupational physicians was 316.6 (95% CI 251.8-381.3) per million. Most reports were of contact dermatitis: dermatologists 68.0 (95% CI 59.8-76.2) per million, occupational physicians 259.7 (95% CI 200.8-318.6) per million. CONCLUSIONS: Information produced by THOR is an important source for calculating incidence rates of occupational skin disease. A range of reporting groups should also be used when building an overall picture of occupational skin disease incidence in the U.K.


Assuntos
Dermatite Ocupacional/epidemiologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Dermatite Ocupacional/diagnóstico , Feminino , Setor de Assistência à Saúde/estatística & dados numéricos , Humanos , Incidência , Indústrias/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Distribuição por Sexo , Serviço Social/estatística & dados numéricos , Reino Unido/epidemiologia , Urticária/epidemiologia
14.
Am J Infect Control ; 34(10): 627-35, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17161737

RESUMO

BACKGROUND: In October 2004, The World Health Organization (WHO) launched the World Alliance for Patient Safety. Within the alliance, the first priority of the Global Patient Safety Challenge is to reduce health care-associated infection. A key action within the challenge is to promote hand hygiene in health care globally as well as at the country level through the campaign "Clean Care is Safer Care." As a result, the WHO is developing Guidelines on Hand Hygiene in Health Care, designed to be applicable throughout the world. METHODS: This paper summarizes one component of the global WHO guidelines related to the impact of hand hygiene on the skin of health care personnel, including a discussion of types of skin reactions associated with hand hygiene, methods to reduce adverse reactions, and factors to consider when selecting hand hygiene products. RESULTS: Health care professionals have a higher prevalence of skin irritation than seen in the general population because of the necessity for frequent hand hygiene during patient care. CONCLUSION: Ways to minimize adverse effects of hand hygiene include selecting less irritating products, using skin moisturizers, and modifying certain hand hygiene practices such as unnecessary washing. Institutions need to consider several factors when selecting hand hygiene products: dermal tolerance and aesthetic preferences of users as well as practical considerations such as convenience, storage, and costs.


Assuntos
Anti-Infecciosos Locais/efeitos adversos , Dermatite de Contato/prevenção & controle , Dermatoses da Mão/prevenção & controle , Desinfecção das Mãos , Pessoal de Saúde , Sabões/efeitos adversos , Anti-Infecciosos Locais/normas , Anti-Infecciosos Locais/provisão & distribuição , Comportamento de Escolha , Infecção Hospitalar/prevenção & controle , Dermatite de Contato/etiologia , Emolientes , Fidelidade a Diretrizes , Dermatoses da Mão/induzido quimicamente , Desinfecção das Mãos/métodos , Desinfecção das Mãos/normas , Pessoal de Saúde/educação , Necessidades e Demandas de Serviços de Saúde , Humanos , Controle de Infecções/métodos , Controle de Infecções/normas , Saúde Ocupacional , Projetos Piloto , Guias de Prática Clínica como Assunto , Higiene da Pele/métodos , Sabões/normas , Sabões/provisão & distribuição , Organização Mundial da Saúde
15.
Br J Nurs ; 15(11): S14-6, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16835510

RESUMO

Over the past decade, nurse prescribing in the community has improved clinical care, providing timely access to many products required for patients to receive appropriate treatment. Until recently, nurses who have qualified as nurse prescribers have only been able to prescribe from a limited list of products. Within the leg ulcer clinic environment, the majority of prescriptions written have been related to wound care. This article describes the introduction of extended independent prescribing (now known as non-medical prescribing) and how this type of prescribing has scope for revolutionizing clinical practice in all healthcare settings. There are, however, many contentious issues for clinicians prescribing in this new role, including systems for communication, clinical governance, and attitudes of other professionals.


Assuntos
Centros Comunitários de Saúde/organização & administração , Enfermagem em Saúde Comunitária/organização & administração , Prescrições de Medicamentos , Úlcera da Perna/enfermagem , Papel do Profissional de Enfermagem , Autonomia Profissional , Assistência Ambulatorial/organização & administração , Celulite (Flegmão)/tratamento farmacológico , Celulite (Flegmão)/etiologia , Competência Clínica , Comunicação , Enfermagem em Saúde Comunitária/educação , Dermatite de Contato/tratamento farmacológico , Dermatite de Contato/etiologia , Documentação , Inglaterra , Acessibilidade aos Serviços de Saúde , Humanos , Relações Interprofissionais , Úlcera da Perna/complicações , Úlcera da Perna/tratamento farmacológico , Avaliação em Enfermagem , Registros de Enfermagem , Dor/tratamento farmacológico , Dor/etiologia , Farmacopeias como Assunto
17.
J Am Acad Dermatol ; 53(2): 303-13, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16021126

RESUMO

Cutaneous irritant and allergic responses account for the vast majority of cases of occupational contact dermatitis (OCD). Although the pathophysiologic responses to these two different exposures are distinct, the clinical differentiation between chronic cumulative irritant contact dermatitis and allergic contact dermatitis can be difficult and frequently requires patch testing. This article reviews the recommended algorithms that clinicians should utilize to assess whether a worker suffers from OCD. The prevalence of OCD, its predisposing factors (both endogenous and exogenous), and prognosis are discussed in depth. Finally, issues surrounding the assessment of impairment and disability resulting from OCD are summarized.


Assuntos
Dermatite de Contato , Dermatite Ocupacional , Avaliação da Deficiência , Fatores Etários , Causalidade , Dermatite de Contato/complicações , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Dermatite Ocupacional/complicações , Dermatite Ocupacional/epidemiologia , Dermatite Ocupacional/etiologia , Humanos , Incidência , Prevalência , Prognóstico , Fatores Sexuais , Indenização aos Trabalhadores
18.
Br J Nurs ; 14(5): 265-6, 268-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15902040

RESUMO

Urinary incontinence is becoming an increasingly common problem for older men and women living in the community. It can have a deleterious effect on quality of life and, although advances have been made in treatments and therapies for this condition, there is still confusion over selection of continence products. This article will explore the problems associated with product selection and discuss alternative advice.


Assuntos
Tampões Absorventes para a Incontinência Urinária/classificação , Tampões Absorventes para a Incontinência Urinária/estatística & dados numéricos , Incontinência Urinária/enfermagem , Idoso , Leitos , Dermatite de Contato/etiologia , Dermatite de Contato/enfermagem , Desenho de Equipamento , Reutilização de Equipamento , Feminino , Custos de Cuidados de Saúde , Humanos , Tampões Absorventes para a Incontinência Urinária/efeitos adversos , Tampões Absorventes para a Incontinência Urinária/economia , Masculino , Úlcera por Pressão/etiologia , Úlcera por Pressão/enfermagem , Úlcera por Pressão/prevenção & controle , Fatores de Risco , Higiene da Pele/instrumentação , Higiene da Pele/métodos , Higiene da Pele/enfermagem , Reino Unido , Incontinência Urinária/economia
19.
Pol J Pathol ; 56(4): 155-60, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16477873

RESUMO

The evaluation of contact hypersensitivity (CHS) reaction is one of the methods used in the assessment of the immune status of an organism after UV radiation. The aim of the study was to compare usefulness of visual scoring system and histological morphometry in the assessment of CHS response after exposure of humans to solar simulated radiation (SSR). The study included 140 healthy volunteers, 33 people were irradiated for 2 days, 34 - for 10 days and 33 - for 30 days with SSR. Forty non-irradiated individuals served as controls. All the volunteers were sensitized with diphenylocyclopropenone (DPCP) 24 h after final exposure. Statistical analysis comparing intensity of CHS reaction based on visual score between irradiated groups and non-irradiated group revealed no differences (p>0.05). We found a significant difference in epidermal thickness between healthy skin and irradiated groups (p<0.05) and a positive correlation between intensity of spongiosis and clinical score for CHS response at 3.2 DPCP site (p<0.000001). A negative correlation between time of irradiation and spongiosis score was revealed (R=-0.28; p<0.001). We conclude that histological examination of biopsies taken from one of the series of elicitation sites is a reliable and sensitive method in the evaluation of CHS response after UVR.


Assuntos
Dermatite de Contato/patologia , Epiderme/patologia , Radiodermite/patologia , Raios Ultravioleta/efeitos adversos , Adulto , Biópsia , Ciclopropanos/administração & dosagem , Dermatite de Contato/etiologia , Dermatite de Contato/prevenção & controle , Relação Dose-Resposta à Radiação , Epiderme/efeitos da radiação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fármacos Fotossensibilizantes/administração & dosagem , Radiodermite/etiologia , Radiodermite/prevenção & controle , Luz Solar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA